Phase 2 studies have shown that higher doses resulted in average weight reductions of around 24% after 48 weeks, with ongoing trials continuing to evaluate its effectiveness
They are different, not automatically safer
For all clinical questions, please consult your medical provider.
Specifications Content: Dihexa (lyophilised) Form: Freeze-dried powder Purity: 98% (HPLC-verified) COA: Certificate of Analysis provided with each batch Storage: 20C prior to dispatch Intended Use: Laboratory research only This product is intended strictly for laboratory research purposes and is not approved for human consumption, animal use, therapeutic applications, or diagnostic procedures.
Distinct Mechanisms of Action: MOTS-c primarily influences metabolic health through mitochondrial function and AMPK pathway activation, while Retatrutide acts as a triple agonist for GIP, GLP-1, and glucagon receptors to regulate appetite and glucose